Cost-effectiveness of adjuvant chemotherapy in early stage breast cancer

被引：0
|
作者：
John, Preethi [1 ]
Bannuru, Raveendhara R. [1 ]
Cohen, Joshua T. [1 ]
Buchsbaum, Rachel J. [1 ]
Erban, John Kalil [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e18887
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18887
引用
收藏
页数：2
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF ADJUVANT TRASTUZUMAB FOR EARLY BREAST CANCER IN ASIA: A SYSTEMATIC REVIEW
    Rafar, Abdul N. R.
    Neoh, C. F.
    Othman, M. F.
    Hong, Y. H.
    VALUE IN HEALTH, 2018, 21 : S14 - S14
  • [22] Cost-Effectiveness of Trastuzumab as Adjuvant Therapy for Early Breast Cancer: A Systematic Review
    Chan, Agnes L. F.
    Leung, Henry W. C.
    Lu, Chin-Li
    Lin, Shun Jin
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (02) : 296 - 303
  • [23] Cost-Effectiveness of Aspirin Adjuvant Therapy in Early Stage Colorectal Cancer in Older Patients
    Soon, Swee Sung
    Chia, Whay-Kuang
    Chan, Mun-ling Sarah
    Ho, Gwo Fuang
    Jian, Xiao
    Deng, Yan Hong
    Tan, Chuen-Seng
    Sharma, Atul
    Segelov, Eva
    Mehta, Shaesta
    Ali, Raghib
    Toh, Han-Chong
    Wee, Hwee-Lin
    PLOS ONE, 2014, 9 (09):
  • [24] Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer
    A Hisashige
    S Yoshida
    S Kodaira
    British Journal of Cancer, 2008, 99 : 1232 - 1238
  • [25] Cost-effectiveness of primary prophylaxis with pegfilgrastim in early-stage breast cancer patients receiving chemotherapy in China
    Xia, Wen
    Wang, Shusen
    Hu, Hao
    Xu, Fei
    Jiang, Kuikui
    Yuan, Zhongyu
    Shi, Yanxia
    Zhao, Kun
    Huang, Jia Jia
    Xue, Cong
    Bi, Xiwen
    Lu, Qianyi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis
    Curtit, E.
    Bellanger, M.
    Nerich, V.
    Hequet, D.
    Frenel, J. S.
    Cristeau, O.
    Rouzier, R.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S59 - S59
  • [27] Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis
    Curtit, Elsa
    Bellanger, Martine Marie
    Nerich, Virginie
    Hequet, Delphine
    Frenel, Jean-Sebastien
    Cristeau, Olivier
    Rouzier, Roman
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses
    Campbell, H. E.
    Epstein, D.
    Bloomfield, D.
    Griffin, S.
    Manca, A.
    Yarnold, J.
    Bliss, J.
    Johnson, L.
    Earl, H.
    Poole, C.
    Hiller, L.
    Dunn, J.
    Hopwood, P.
    Barrett-Lee, P.
    Ellis, P.
    Cameron, D.
    Harris, A. L.
    Gray, A. M.
    Sculpher, M. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (17) : 2517 - 2530
  • [29] COMPARATIVE COST-EFFECTIVENESS OF EARLY-STAGE BREAST CANCER TREATMENTS IN THE ELDERLY
    Ali, A. A.
    Xiao, H.
    Tawk, R. H.
    Campbell, E. S.
    Semykina, A.
    Montero, A. J.
    Diaby, V
    VALUE IN HEALTH, 2017, 20 (05) : A9 - A9
  • [30] COST-EFFECTIVENESS OF ADJUVANT THERAPY WITH TRASTUZUMAB IN THE TREATMENT OF EARLY BREAST CANCER (EBC) IN ROMANIA
    Grecea, D.
    Baculea, S.
    Radu, P. C.
    Pana, B.
    Szkultecka-Debek, M.
    VALUE IN HEALTH, 2010, 13 (03) : A42 - A42
12345